PubMed

Safety and immunogenicity of an MF59trade mark-adjuvanted subunit influenza vaccine in elderly Chinese subjects.

Li R, Fang H, Li Y, Liu Y, Pellegrini M, Podda A.

Immun Ageing. 2008 Feb 20;5:2.PMID: 18289372 [PubMed - in process]Related articlesFree article

[Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly]

Li RC, Fang HH, Li YP, Liu YP, Nong Y, Huang GB.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jun;29(6):548-51. Chinese. PMID: 19040034 [PubMed - indexed for MEDLINE]Related articles

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

Squarcione S, Sgricia S, Biasio LR, Perinetti E.

Vaccine. 2003 Mar 7;21(11-12):1268-74.PMID: 12559808 [PubMed - indexed for MEDLINE]Related articles

[Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]

Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Jul;24(7):570-3. Chinese. PMID: 12975010 [PubMed - indexed for MEDLINE]Related articles

Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults.

Frey S, Poland G, Percell S, Podda A.

Vaccine. 2003 Oct 1;21(27-30):4234-7.PMID: 14505903 [PubMed - indexed for MEDLINE]Related articles

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children.

Kanra G, Marchisio P, Feiterna-Sperling C, Gaedicke G, Lazar H, Durrer P, Kürsteiner O, Herzog C, Kara A, Principi N.

Pediatr Infect Dis J. 2004 Apr;23(4):300-6. Erratum in: Pediatr Infect Dis J. 2004 Jun;23(6):503. PMID: 15071282 [PubMed - indexed for MEDLINE]Related articles

MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.

Baldo V, Baldovin T, Floreani A, Carraro AM, Trivello R; Family Medicine Group of Pianiga.

Vaccine. 2007 May 16;25(20):3955-61. Epub 2007 Mar 6.PMID: 17383057 [PubMed - indexed for MEDLINE]Related articles

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis.

Banzhoff A, Nacci P, Podda A.

Gerontology. 2003 May-Jun;49(3):177-84.PMID: 12679609 [PubMed - indexed for MEDLINE]Related articles

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine.

Podda A.

Vaccine. 2001 Mar 21;19(17-19):2673-80.PMID: 11257408 [PubMed - indexed for MEDLINE]Related articles

Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.

Sindoni D, La Fauci V, Squeri R, Cannavò G, Bacilieri S, Panatto D, Gasparini R, Amicizia D.

J Prev Med Hyg. 2009 Jun;50(2):121-6.PMID: 20099444 [PubMed - in process]Related articles

Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.

Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.

Vaccine. 2009 Aug 27;27(39):5357-62. Epub 2009 Jul 14.PMID: 19607951 [PubMed - indexed for MEDLINE]Related articles

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects.

Gasparini R, Pozzi T, Montomoli E, Fragapane E, Senatore F, Minutello M, Podda A.

Eur J Epidemiol. 2001;17(2):135-40.PMID: 11599686 [PubMed - indexed for MEDLINE]Related articles

Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.

de Bruijn I, Meyer I, Gerez L, Nauta J, Giezeman K, Palache B.

Vaccine. 2007 Dec 21;26(1):119-27. Epub 2007 Nov 12.PMID: 18063446 [PubMed - indexed for MEDLINE]Related articles

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons.

Minutello M, Senatore F, Cecchinelli G, Bianchi M, Andreani T, Podda A, Crovari P.

Vaccine. 1999 Jan;17(2):99-104.PMID: 9987141 [PubMed - indexed for MEDLINE]Related articles

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.

Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J.

Vaccine. 2009 Jun 2;27(27):3561-7. Epub 2009 Apr 10.PMID: 19464535 [PubMed - indexed for MEDLINE]Related articles

Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients.

de Roux A, Marx A, Burkhardt O, Schweiger B, Borkowski A, Banzhoff A, Pletz MW, Lode H.

Vaccine. 2006 Mar 6;24(10):1537-42. Epub 2005 Oct 19.PMID: 16288937 [PubMed - indexed for MEDLINE]Related articles

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly.

De Donato S, Granoff D, Minutello M, Lecchi G, Faccini M, Agnello M, Senatore F, Verweij P, Fritzell B, Podda A.

Vaccine. 1999 Aug 6;17(23-24):3094-101.PMID: 10462245 [PubMed - indexed for MEDLINE]Related articles

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM.

Vaccine. 2010 Feb 17;28(7):1740-5. Epub 2009 Dec 22.PMID: 20034605 [PubMed - in process]Related articles

Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.

Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, Barben JL, Rarrick K, Stek JE, Chung MO, Schödel FP, Wang WW, Xu J, Chan IS, Silber JL, Schlienger K.

J Am Geriatr Soc. 2007 Oct;55(10):1499-507.PMID: 17908055 [PubMed - indexed for MEDLINE]Related articles

Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly.

Ruf BR, Colberg K, Frick M, Preusche A.

Infection. 2004 Aug;32(4):191-8.PMID: 15293073 [PubMed - indexed for MEDLINE]Related articles